Stock Earnings

Question 1

What are Celldex Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Celldex Therapeutics Inc has a total asset of $582, Net loss of $-258

Question 2

What are the key financial ratios for CLDX?

Accepted Answer

Celldex Therapeutics Inc's Current ratio is 10.58, has a Net margin is -25,800, sales per share of $0.01.

Question 3

How is Celldex Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Celldex Therapeutics Inc largest revenue segment is Novel Therapeutics, at a revenue of 7,020,000 in the most earnings release.For geography, United States is the primary market for Celldex Therapeutics Inc, at a revenue of 7,020,000.

Question 4

Is Celldex Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Celldex Therapeutics Inc has a net loss of $-258

Question 5

Does Celldex Therapeutics Inc have any liabilities?

Accepted Answer

yes, Celldex Therapeutics Inc has liability of 55

Question 6

How many outstanding shares for Celldex Therapeutics Inc?

Accepted Answer

Celldex Therapeutics Inc has a total outstanding shares of 66.54

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	0	1	7	6	2	4
Revenue Growth (YoY)	-100%	-86%	17%	200%	-50%	-43%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	44	43	38	30	27	20
Research & Development	265	245	163	118	82	53
Operating Expenses	309	288	202	148	102	72
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-283	-258	-157	-141	-112	-70
Income Tax Expense	--	0	0	0	0	0
Net Income	-283	-258	-157	-141	-112	-70
Net Income Growth	59%	64%	11%	26%	60%	19%
Shares Outstanding (Diluted)	66.56	66.42	64.39	48.44	46.89	42.87
Shares Change (YoY)	0%	3%	33%	3%	9%	45%
EPS (Diluted)	-4.26	-3.89	-2.45	-2.91	-2.4	-1.64
EPS Growth	57.99%	59%	-16%	22%	46%	-19%
Free Cash Flow	-226	-213	-159	-109	-105	-62
Free Cash Flow Per Share	-3.39	-3.2	-2.46	-2.24	-2.23	-1.44
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	-28,700%	-2,785.71%	-2,366.66%	-5,000%	-1,675%
Profit Margin	0%	-25,800%	-2,242.85%	-2,350%	-5,600%	-1,750%
Free Cash Flow Margin	0%	-21,300%	-2,271.42%	-1,816.66%	-5,250%	-1,550%
EBITDA	-306	-284	-192	-139	-98	-64
EBITDA Margin	0%	-28,400%	-2,742.85%	-2,316.66%	-4,900%	-1,600%
D&A For EBITDA	3	3	3	3	2	3
EBIT	-309	-287	-195	-142	-100	-67
EBIT Margin	0%	-28,700%	-2,785.71%	-2,366.66%	-5,000%	-1,675%
Effective Tax Rate	--	0%	0%	0%	0%	0%

Celldex Therapeutics Inc (CLDX) Price

CLDX Stock Price Chart

CLDX Income

Follow-Up Questions